Profile
Karin Hoogendoorn is currently a Director at the Centre For Advanced Medical Products.
Previously, she worked as an Associate Director at Novartis AG and Janssen Biologics BV.
She also served as a Director at Idogen AB and an Independent Director at Elicera Therapeutics AB. Additionally, she was the Head of Chemistry, Manufacturing & Controls at Mendus AB. Dr. Hoogendoorn holds a graduate degree from the University of Leiden and a doctorate degree from the University of Utrecht.
Karin Hoogendoorn active positions
| Companies | Position | Start |
|---|---|---|
Centre For Advanced Medical Products | Director/Board Member | - |
Former positions of Karin Hoogendoorn
| Companies | Position | End |
|---|---|---|
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Director/Board Member | 2020-05-11 |
| ELICERA THERAPEUTICS AB | Director/Board Member | - |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Manufactures, acquires and markets biopharmaceutical therapies | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
| MENDUS AB | Corporate Officer/Principal | - |
Training of Karin Hoogendoorn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Manufactures, acquires and markets biopharmaceutical therapies | Health Technology |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Health Technology |
Elicera Therapeutics AB
Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
Centre For Advanced Medical Products |
- Stock Market
- Insiders
- Karin Hoogendoorn
















